BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 19463339)

  • 21. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
    Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
    Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponin I concentrations following primary percutaneous coronary intervention predict large infarct size and left ventricular dysfunction in patients with ST-segment elevation acute myocardial infarction.
    Ohlmann P; Monassier JP; Michotey MO; Berenger N; Jacquemin L; Laval G; Roul G; Schneider F
    Atherosclerosis; 2003 May; 168(1):181-9. PubMed ID: 12732402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomes.
    Sanchez-Ross M; Oghlakian G; Maher J; Patel B; Mazza V; Hom D; Dhruva V; Langley D; Palmaro J; Ahmed S; Kaluski E; Klapholz M
    JACC Cardiovasc Interv; 2011 Feb; 4(2):222-7. PubMed ID: 21349462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.
    Rodriguez-Granillo GA; Rosales MA; Baum S; Rennes P; Rodriguez-Pagani C; Curotto V; Fernandez-Pereira C; Llaurado C; Risau G; Degrossi E; Doval HC; Rodriguez AE
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1072-81. PubMed ID: 19761985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction.
    Kitabata H; Imanishi T; Kubo T; Takarada S; Kashiwagi M; Matsumoto H; Tsujioka H; Ikejima H; Arita Y; Okochi K; Kuroi A; Ueno S; Kataiwa H; Tanimoto T; Yamano T; Hirata K; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):263-72. PubMed ID: 19356570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
    Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary intervention.
    Tzivoni D; Balkin J; Bär FW; Hibberd M; Reiber JH; Cowing G
    Am J Cardiol; 2009 Jan; 103(1):1-4. PubMed ID: 19101220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).
    Eitel I; Friedenberger J; Fuernau G; Dumjahn A; Desch S; Schuler G; Thiele H
    Clin Res Cardiol; 2011 May; 100(5):425-32. PubMed ID: 21125288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Rasoul S; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Marcel Gosselink AT; Zijlstra F; Suryapranata H; van 't Hof AW;
    Coron Artery Dis; 2009 Sep; 20(6):415-21. PubMed ID: 19641460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study.
    Huang R; Yao K; Sun A; Qian J; Ge L; Zhang Y; Niu Y; Wang K; Zou Y; Ge J
    Stem Cell Res Ther; 2015 May; 6(1):112. PubMed ID: 26021558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troponin T levels and infarct size by SPECT myocardial perfusion imaging.
    Arruda-Olson AM; Roger VL; Jaffe AS; Hodge DO; Gibbons RJ; Miller TD
    JACC Cardiovasc Imaging; 2011 May; 4(5):523-33. PubMed ID: 21565741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction.
    Gu YL; Haeck JD; Vogelzang M; Bilodeau L; Krucoff MW; Tijssen JG; de Winter RJ; Zijlstra F; Koch KT
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):174-81. PubMed ID: 20518003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.